Table of Content

1 Animal Biological Vaccine Market Overview
1.1 Product Overview and Scope of Animal Biological Vaccine
1.2 Animal Biological Vaccine Segment by Type
1.2.1 Global Animal Biological Vaccine Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Oral
1.2.3 Subcutaneous
1.2.4 Intramuscular
1.2.5 Others
1.3 Animal Biological Vaccine Segment by Application
1.3.1 Animal Biological Vaccine Sales Comparison by Application: (2021-2027)
1.3.2 Porcine
1.3.3 Poultry
1.3.4 Livestock
1.3.5 Companion Animals
1.3.6 Aquaculture
1.4 Global Animal Biological Vaccine Market Size Estimates and Forecasts
1.4.1 Global Animal Biological Vaccine Revenue 2016-2027
1.4.2 Global Animal Biological Vaccine Sales 2016-2027
1.4.3 Animal Biological Vaccine Market Size by Region: 2016 Versus 2021 Versus 2027

2 Animal Biological Vaccine Market Competition by Manufacturers
2.1 Global Animal Biological Vaccine Sales Market Share by Manufacturers (2016-2021)
2.2 Global Animal Biological Vaccine Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Animal Biological Vaccine Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Animal Biological Vaccine Manufacturing Sites, Area Served, Product Type
2.5 Animal Biological Vaccine Market Competitive Situation and Trends
2.5.1 Animal Biological Vaccine Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Animal Biological Vaccine Players Market Share by Revenue
2.5.3 Global Animal Biological Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Animal Biological Vaccine Retrospective Market Scenario by Region
3.1 Global Animal Biological Vaccine Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Animal Biological Vaccine Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Animal Biological Vaccine Market Facts & Figures by Country
3.3.1 North America Animal Biological Vaccine Sales by Country
3.3.2 North America Animal Biological Vaccine Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Animal Biological Vaccine Market Facts & Figures by Country
3.4.1 Europe Animal Biological Vaccine Sales by Country
3.4.2 Europe Animal Biological Vaccine Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Animal Biological Vaccine Market Facts & Figures by Region
3.5.1 Asia Pacific Animal Biological Vaccine Sales by Region
3.5.2 Asia Pacific Animal Biological Vaccine Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Animal Biological Vaccine Market Facts & Figures by Country
3.6.1 Latin America Animal Biological Vaccine Sales by Country
3.6.2 Latin America Animal Biological Vaccine Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Animal Biological Vaccine Market Facts & Figures by Country
3.7.1 Middle East and Africa Animal Biological Vaccine Sales by Country
3.7.2 Middle East and Africa Animal Biological Vaccine Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Animal Biological Vaccine Historic Market Analysis by Type
4.1 Global Animal Biological Vaccine Sales Market Share by Type (2016-2021)
4.2 Global Animal Biological Vaccine Revenue Market Share by Type (2016-2021)
4.3 Global Animal Biological Vaccine Price by Type (2016-2021)

5 Global Animal Biological Vaccine Historic Market Analysis by Application
5.1 Global Animal Biological Vaccine Sales Market Share by Application (2016-2021)
5.2 Global Animal Biological Vaccine Revenue Market Share by Application (2016-2021)
5.3 Global Animal Biological Vaccine Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Animal Biological Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Merck Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Zoetis
6.2.1 Zoetis Corporation Information
6.2.2 Zoetis Description and Business Overview
6.2.3 Zoetis Animal Biological Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Zoetis Product Portfolio
6.2.5 Zoetis Recent Developments/Updates
6.3 Merial/Sanofi
6.3.1 Merial/Sanofi Corporation Information
6.3.2 Merial/Sanofi Description and Business Overview
6.3.3 Merial/Sanofi Animal Biological Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Merial/Sanofi Product Portfolio
6.3.5 Merial/Sanofi Recent Developments/Updates
6.4 Boehringer Ingelheim
6.4.1 Boehringer Ingelheim Corporation Information
6.4.2 Boehringer Ingelheim Description and Business Overview
6.4.3 Boehringer Ingelheim Animal Biological Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Boehringer Ingelheim Product Portfolio
6.4.5 Boehringer Ingelheim Recent Developments/Updates
6.5 Ceva
6.5.1 Ceva Corporation Information
6.5.2 Ceva Description and Business Overview
6.5.3 Ceva Animal Biological Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Ceva Product Portfolio
6.5.5 Ceva Recent Developments/Updates
6.6 CAHIC
6.6.1 CAHIC Corporation Information
6.6.2 CAHIC Description and Business Overview
6.6.3 CAHIC Animal Biological Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.6.4 CAHIC Product Portfolio
6.6.5 CAHIC Recent Developments/Updates
6.7 HVRI
6.6.1 HVRI Corporation Information
6.6.2 HVRI Description and Business Overview
6.6.3 HVRI Animal Biological Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.4.4 HVRI Product Portfolio
6.7.5 HVRI Recent Developments/Updates
6.8 Ringpu Biology
6.8.1 Ringpu Biology Corporation Information
6.8.2 Ringpu Biology Description and Business Overview
6.8.3 Ringpu Biology Animal Biological Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Ringpu Biology Product Portfolio
6.8.5 Ringpu Biology Recent Developments/Updates
6.9 Yebio
6.9.1 Yebio Corporation Information
6.9.2 Yebio Description and Business Overview
6.9.3 Yebio Animal Biological Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Yebio Product Portfolio
6.9.5 Yebio Recent Developments/Updates
6.10 DHN
6.10.1 DHN Corporation Information
6.10.2 DHN Description and Business Overview
6.10.3 DHN Animal Biological Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.10.4 DHN Product Portfolio
6.10.5 DHN Recent Developments/Updates
6.11 WINSUN
6.11.1 WINSUN Corporation Information
6.11.2 WINSUN Animal Biological Vaccine Description and Business Overview
6.11.3 WINSUN Animal Biological Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.11.4 WINSUN Product Portfolio
6.11.5 WINSUN Recent Developments/Updates
6.12 Elanco/Eli Lilly
6.12.1 Elanco/Eli Lilly Corporation Information
6.12.2 Elanco/Eli Lilly Animal Biological Vaccine Description and Business Overview
6.12.3 Elanco/Eli Lilly Animal Biological Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Elanco/Eli Lilly Product Portfolio
6.12.5 Elanco/Eli Lilly Recent Developments/Updates
6.13 Virbac
6.13.1 Virbac Corporation Information
6.13.2 Virbac Animal Biological Vaccine Description and Business Overview
6.13.3 Virbac Animal Biological Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Virbac Product Portfolio
6.13.5 Virbac Recent Developments/Updates
6.14 Jinyu Bio-Technology
6.14.1 Jinyu Bio-Technology Corporation Information
6.14.2 Jinyu Bio-Technology Animal Biological Vaccine Description and Business Overview
6.14.3 Jinyu Bio-Technology Animal Biological Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Jinyu Bio-Technology Product Portfolio
6.14.5 Jinyu Bio-Technology Recent Developments/Updates
6.15 ChengDu Tecbond
6.15.1 ChengDu Tecbond Corporation Information
6.15.2 ChengDu Tecbond Animal Biological Vaccine Description and Business Overview
6.15.3 ChengDu Tecbond Animal Biological Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.15.4 ChengDu Tecbond Product Portfolio
6.15.5 ChengDu Tecbond Recent Developments/Updates
6.16 CAVAC
6.16.1 CAVAC Corporation Information
6.16.2 CAVAC Animal Biological Vaccine Description and Business Overview
6.16.3 CAVAC Animal Biological Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.16.4 CAVAC Product Portfolio
6.16.5 CAVAC Recent Developments/Updates
6.17 Kyoto Biken
6.17.1 Kyoto Biken Corporation Information
6.17.2 Kyoto Biken Animal Biological Vaccine Description and Business Overview
6.17.3 Kyoto Biken Animal Biological Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.17.4 Kyoto Biken Product Portfolio
6.17.5 Kyoto Biken Recent Developments/Updates
6.18 FATRO
6.18.1 FATRO Corporation Information
6.18.2 FATRO Animal Biological Vaccine Description and Business Overview
6.18.3 FATRO Animal Biological Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.18.4 FATRO Product Portfolio
6.18.5 FATRO Recent Developments/Updates
6.19 Vaksindo
6.19.1 Vaksindo Corporation Information
6.19.2 Vaksindo Animal Biological Vaccine Description and Business Overview
6.19.3 Vaksindo Animal Biological Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.19.4 Vaksindo Product Portfolio
6.19.5 Vaksindo Recent Developments/Updates
6.20 Bio-Labs
6.20.1 Bio-Labs Corporation Information
6.20.2 Bio-Labs Animal Biological Vaccine Description and Business Overview
6.20.3 Bio-Labs Animal Biological Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.20.4 Bio-Labs Product Portfolio
6.20.5 Bio-Labs Recent Developments/Updates
6.21 Avimex Animal
6.21.1 Avimex Animal Corporation Information
6.21.2 Avimex Animal Animal Biological Vaccine Description and Business Overview
6.21.3 Avimex Animal Animal Biological Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.21.4 Avimex Animal Product Portfolio
6.21.5 Avimex Animal Recent Developments/Updates

7 Animal Biological Vaccine Manufacturing Cost Analysis
7.1 Animal Biological Vaccine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Animal Biological Vaccine
7.4 Animal Biological Vaccine Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Animal Biological Vaccine Distributors List
8.3 Animal Biological Vaccine Customers

9 Animal Biological Vaccine Market Dynamics
9.1 Animal Biological Vaccine Industry Trends
9.2 Animal Biological Vaccine Growth Drivers
9.3 Animal Biological Vaccine Market Challenges
9.4 Animal Biological Vaccine Market Restraints

10 Global Market Forecast
10.1 Animal Biological Vaccine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Animal Biological Vaccine by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Animal Biological Vaccine by Type (2022-2027)
10.2 Animal Biological Vaccine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Animal Biological Vaccine by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Animal Biological Vaccine by Application (2022-2027)
10.3 Animal Biological Vaccine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Animal Biological Vaccine by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Animal Biological Vaccine by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Animal Biological Vaccine Sales (K Doses) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Animal Biological Vaccine Sales (K Doses) Comparison by Application (2021-2027)
Table 3. Global Animal Biological Vaccine Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Animal Biological Vaccine Covered in This Study
Table 5. Global Animal Biological Vaccine Sales (K Doses) of Key Manufacturers (2016-2021)
Table 6. Global Animal Biological Vaccine Sales Share by Manufacturers (2016-2021)
Table 7. Global Animal Biological Vaccine Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Animal Biological Vaccine Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Animal Biological Vaccine Average Price (USD/Dose) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Animal Biological Vaccine Manufacturing Sites and Area Served
Table 11. Manufacturers Animal Biological Vaccine Product Type
Table 12. Global Animal Biological Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Animal Biological Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Animal Biological Vaccine as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Animal Biological Vaccine Sales by Region (2016-2021) & (K Doses)
Table 16. Global Animal Biological Vaccine Sales Market Share by Region (2016-2021)
Table 17. Global Animal Biological Vaccine Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Animal Biological Vaccine Sales by Country (2016-2021) & (K Doses)
Table 19. North America Animal Biological Vaccine Sales Market Share by Country (2016-2021)
Table 20. North America Animal Biological Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Animal Biological Vaccine Revenue Market Share by Country (2016-2021)
Table 22. Europe Animal Biological Vaccine Sales by Country (2016-2021) & (K Doses)
Table 23. Europe Animal Biological Vaccine Sales Market Share by Country (2016-2021)
Table 24. Europe Animal Biological Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Animal Biological Vaccine Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Animal Biological Vaccine Sales by Region (2016-2021) & (K Doses)
Table 27. Asia Pacific Animal Biological Vaccine Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Animal Biological Vaccine Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Animal Biological Vaccine Revenue Market Share by Region (2016-2021)
Table 30. Latin America Animal Biological Vaccine Sales by Country (2016-2021) & (K Doses)
Table 31. Latin America Animal Biological Vaccine Sales Market Share by Country (2016-2021)
Table 32. Latin America Animal Biological Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Animal Biological Vaccine Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Animal Biological Vaccine Sales by Country (2016-2021) & (K Doses)
Table 35. Middle East and Africa Animal Biological Vaccine Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Animal Biological Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Animal Biological Vaccine Revenue Market Share by Country (2016-2021)
Table 38. Global Animal Biological Vaccine Sales (K Doses) by Type (2016-2021)
Table 39. Global Animal Biological Vaccine Sales Market Share by Type (2016-2021)
Table 40. Global Animal Biological Vaccine Revenue (Million US$) by Type (2016-2021)
Table 41. Global Animal Biological Vaccine Revenue Share by Type (2016-2021)
Table 42. Global Animal Biological Vaccine Price (USD/Dose) by Type (2016-2021)
Table 43. Global Animal Biological Vaccine Sales (K Doses) by Application (2016-2021)
Table 44. Global Animal Biological Vaccine Sales Market Share by Application (2016-2021)
Table 45. Global Animal Biological Vaccine Revenue (Million US$) by Application (2016-2021)
Table 46. Global Animal Biological Vaccine Revenue Share by Application (2016-2021)
Table 47. Global Animal Biological Vaccine Price (USD/Dose) by Application (2016-2021)
Table 48. Merck Corporation Information
Table 49. Merck Description and Business Overview
Table 50. Merck Animal Biological Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 51. Merck Animal Biological Vaccine Product
Table 52. Merck Recent Developments/Updates
Table 53. Zoetis Corporation Information
Table 54. Zoetis Description and Business Overview
Table 55. Zoetis Animal Biological Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 56. Zoetis Animal Biological Vaccine Product
Table 57. Zoetis Recent Developments/Updates
Table 58. Merial/Sanofi Corporation Information
Table 59. Merial/Sanofi Description and Business Overview
Table 60. Merial/Sanofi Animal Biological Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 61. Merial/Sanofi Animal Biological Vaccine Product
Table 62. Merial/Sanofi Recent Developments/Updates
Table 63. Boehringer Ingelheim Corporation Information
Table 64. Boehringer Ingelheim Description and Business Overview
Table 65. Boehringer Ingelheim Animal Biological Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 66. Boehringer Ingelheim Animal Biological Vaccine Product
Table 67. Boehringer Ingelheim Recent Developments/Updates
Table 68. Ceva Corporation Information
Table 69. Ceva Description and Business Overview
Table 70. Ceva Animal Biological Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 71. Ceva Animal Biological Vaccine Product
Table 72. Ceva Recent Developments/Updates
Table 73. CAHIC Corporation Information
Table 74. CAHIC Description and Business Overview
Table 75. CAHIC Animal Biological Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 76. CAHIC Animal Biological Vaccine Product
Table 77. CAHIC Recent Developments/Updates
Table 78. HVRI Corporation Information
Table 79. HVRI Description and Business Overview
Table 80. HVRI Animal Biological Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 81. HVRI Animal Biological Vaccine Product
Table 82. HVRI Recent Developments/Updates
Table 83. Ringpu Biology Corporation Information
Table 84. Ringpu Biology Description and Business Overview
Table 85. Ringpu Biology Animal Biological Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 86. Ringpu Biology Animal Biological Vaccine Product
Table 87. Ringpu Biology Recent Developments/Updates
Table 88. Yebio Corporation Information
Table 89. Yebio Description and Business Overview
Table 90. Yebio Animal Biological Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 91. Yebio Animal Biological Vaccine Product
Table 92. Yebio Recent Developments/Updates
Table 93. DHN Corporation Information
Table 94. DHN Description and Business Overview
Table 95. DHN Animal Biological Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 96. DHN Animal Biological Vaccine Product
Table 97. DHN Recent Developments/Updates
Table 98. WINSUN Corporation Information
Table 99. WINSUN Description and Business Overview
Table 100. WINSUN Animal Biological Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 101. WINSUN Animal Biological Vaccine Product
Table 102. WINSUN Recent Developments/Updates
Table 103. Elanco/Eli Lilly Corporation Information
Table 104. Elanco/Eli Lilly Description and Business Overview
Table 105. Elanco/Eli Lilly Animal Biological Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 106. Elanco/Eli Lilly Animal Biological Vaccine Product
Table 107. Elanco/Eli Lilly Recent Developments/Updates
Table 108. Virbac Corporation Information
Table 109. Virbac Description and Business Overview
Table 110. Virbac Animal Biological Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 111. Virbac Animal Biological Vaccine Product
Table 112. Virbac Recent Developments/Updates
Table 113. Jinyu Bio-Technology Corporation Information
Table 114. Jinyu Bio-Technology Description and Business Overview
Table 115. Jinyu Bio-Technology Animal Biological Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 116. Jinyu Bio-Technology Animal Biological Vaccine Product
Table 117. Jinyu Bio-Technology Recent Developments/Updates
Table 118. ChengDu Tecbond Corporation Information
Table 119. ChengDu Tecbond Description and Business Overview
Table 120. ChengDu Tecbond Animal Biological Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 121. ChengDu Tecbond Animal Biological Vaccine Product
Table 122. ChengDu Tecbond Recent Developments/Updates
Table 123. CAVAC Corporation Information
Table 124. CAVAC Description and Business Overview
Table 125. CAVAC Animal Biological Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 126. CAVAC Animal Biological Vaccine Product
Table 127. CAVAC Recent Developments/Updates
Table 128. Kyoto Biken Corporation Information
Table 129. Kyoto Biken Description and Business Overview
Table 130. Kyoto Biken Animal Biological Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 131. Kyoto Biken Animal Biological Vaccine Product
Table 132. Kyoto Biken Recent Developments/Updates
Table 133. FATRO Corporation Information
Table 134. FATRO Description and Business Overview
Table 135. FATRO Animal Biological Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 136. FATRO Animal Biological Vaccine Product
Table 137. FATRO Recent Developments/Updates
Table 138. Vaksindo Corporation Information
Table 139. Vaksindo Description and Business Overview
Table 140. Vaksindo Animal Biological Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 141. Vaksindo Animal Biological Vaccine Product
Table 142. Vaksindo Recent Developments/Updates
Table 143. Bio-Labs Corporation Information
Table 144. Bio-Labs Description and Business Overview
Table 145. Bio-Labs Animal Biological Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 146. Bio-Labs Animal Biological Vaccine Product
Table 147. Bio-Labs Recent Developments/Updates
Table 148. Avimex Animal Corporation Information
Table 149. Avimex Animal Description and Business Overview
Table 150. Avimex Animal Animal Biological Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 151. Avimex Animal Animal Biological Vaccine Product
Table 152. Avimex Animal Recent Developments/Updates
Table 153. Production Base and Market Concentration Rate of Raw Material
Table 154. Key Suppliers of Raw Materials
Table 155. Animal Biological Vaccine Distributors List
Table 156. Animal Biological Vaccine Customers List
Table 157. Animal Biological Vaccine Market Trends
Table 158. Animal Biological Vaccine Growth Drivers
Table 159. Animal Biological Vaccine Market Restraints
Table 160. Global Animal Biological Vaccine Sales Forecast by Type (2022-2027) & (K Doses)
Table 161. Global Animal Biological Vaccine Sales Market Share Forecast by Type (2022-2027)
Table 162. Global Animal Biological Vaccine Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 163. Global Animal Biological Vaccine Revenue Market Share Forecast by Type (2022-2027)
Table 164. Global Animal Biological Vaccine Sales Forecast by Application (2022-2027) & (K Doses)
Table 165. Global Animal Biological Vaccine Sales Market Share Forecast by Application (2022-2027)
Table 166. Global Animal Biological Vaccine Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 167. Global Animal Biological Vaccine Revenue Market Share Forecast by Application (2022-2027)
Table 168. Global Animal Biological Vaccine Sales Forecast by Region (2022-2027) & (K Doses)
Table 169. Global Animal Biological Vaccine Sales Market Share Forecast by Region (2022-2027)
Table 170. Global Animal Biological Vaccine Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 171. Global Animal Biological Vaccine Revenue Market Share Forecast by Region (2022-2027)
Table 172. Research Programs/Design for This Report
Table 173. Key Data Information from Secondary Sources
Table 174. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Animal Biological Vaccine
Figure 2. Global Animal Biological Vaccine Market Share by Type in 2020 & 2027
Figure 3. Oral Product Picture
Figure 4. Subcutaneous Product Picture
Figure 5. Intramuscular Product Picture
Figure 6. Others Product Picture
Figure 7. Global Animal Biological Vaccine Market Share by Application in 2020 & 2027
Figure 8. Porcine
Figure 9. Poultry
Figure 10. Livestock
Figure 11. Companion Animals
Figure 12. Aquaculture
Figure 13. Global Animal Biological Vaccine Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Animal Biological Vaccine Market Size 2016-2027 (US$ Million)
Figure 15. Global Animal Biological Vaccine Sales 2016-2027 (K Doses)
Figure 16. Global Animal Biological Vaccine Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 17. Animal Biological Vaccine Sales Share by Manufacturers in 2020
Figure 18. Global Animal Biological Vaccine Revenue Share by Manufacturers in 2020
Figure 19. The Global 5 and 10 Largest Animal Biological Vaccine Players: Market Share by Revenue in 2020
Figure 20. Animal Biological Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 21. Global Animal Biological Vaccine Sales Market Share by Region (2016-2021)
Figure 22. Global Animal Biological Vaccine Sales Market Share by Region in 2020
Figure 23. Global Animal Biological Vaccine Revenue Market Share by Region (2016-2021)
Figure 24. Global Animal Biological Vaccine Revenue Market Share by Region in 2020
Figure 25. U.S. Animal Biological Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Canada Animal Biological Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Germany Animal Biological Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. France Animal Biological Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. U.K. Animal Biological Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Italy Animal Biological Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Russia Animal Biological Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. China Animal Biological Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Japan Animal Biological Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. South Korea Animal Biological Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. India Animal Biological Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Australia Animal Biological Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Taiwan Animal Biological Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Indonesia Animal Biological Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Thailand Animal Biological Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Malaysia Animal Biological Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Philippines Animal Biological Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Vietnam Animal Biological Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Mexico Animal Biological Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Brazil Animal Biological Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Argentina Animal Biological Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Turkey Animal Biological Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Saudi Arabia Animal Biological Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. U.A.E Animal Biological Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 49. Sales Market Share of Animal Biological Vaccine by Type (2016-2021)
Figure 50. Sales Market Share of Animal Biological Vaccine by Application (2016-2021)
Figure 51. Sales Market Share of Animal Biological Vaccine by Application in 2020
Figure 52. Revenue Share of Animal Biological Vaccine by Application (2016-2021)
Figure 53. Revenue Share of Animal Biological Vaccine by Application in 2020
Figure 54. Manufacturing Cost Structure of Animal Biological Vaccine
Figure 55. Manufacturing Process Analysis of Animal Biological Vaccine
Figure 56. Animal Biological Vaccine Industrial Chain Analysis
Figure 57. Channels of Distribution
Figure 58. Distributors Profiles
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed